Nationwide
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
ModernaTX, Inc.
Ph 4·~1.5yr·6 sites in GA, LA, MS +2
ModernaTX, Inc.
University of California, San Francisco
Aptitude Medical Systems
Stephanie B. Seminara, MD
University of Minnesota
Jon Simmons
Massachusetts General Hospital
ModernaTX, Inc.
ModernaTX, Inc.
University of Illinois at Chicago
University of Chicago
Columbia University
Ohio State University Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Loma Linda University
The University of Texas Health Science Center, Houston
Vanderbilt University Medical Center
Duke University